MedTrace Logo

Urinary Circulating Tumor DNA Detection in Non-small Cell Lung Cancer: a Prospective Study

NCT02907606 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 45

Last updated 2016-09-20

No results posted yet for this study

Summary

This study will evaluate the feasibility and effectiveness of urinary ctDNA detection and dynamic monitoring during treatment of NSCLC patients prospectively,by collecting and detecting tumor tissues, peripheral blood samples and urine samples of NSCLC patients.

Conditions

  • Carcinoma
  • Non-small-cell Lung Cancer
  • Lung Neoplasms

Sponsors & Collaborators

  • San Valley Biotechnology Incorporated

    collaborator UNKNOWN

  • Peking University People's Hospital

    lead OTHER

Principal Investigators

  • Xiao Li, M.D · Peking University People's Hospital

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-09-30
Primary Completion
2017-06-30
Completion
2020-08-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02907606 on ClinicalTrials.gov